Interactive demo · Sample data
The reporting we build, live.
A working sample of the leadership dashboards we ship — ARR, churn, cohort retention, CAC payback and burn in one view. Numbers are illustrative for a fictional Series A SaaS.
Demo mode · No data is sent or stored.
Walkthrough · Executive dashboard in action
A short tour of the reporting layer — KPIs, drill-downs, and scenario views.
Executive Dashboards
Real-time visibility into business performance.
Automated Reporting
Management reports updated in less than one minute.
Data Integration
CRM, ERP, HR, finance, and operational systems connected.
FP&A Solutions
Budgeting, forecasting, KPI tracking, and variance analysis.
ARR
€5.90M
+181% YTD
Net revenue retention
113%
Healthy
Gross churn
2.0%
On target
CAC payback
9 mo
Efficient
Base case — steady execution, no surprises.
- ARR growth is on plan at +181% annualized. Runway sits at ~16 months — comfortable for the next fundraise cycle.
- Net retention at 113% is healthy for Series A; churn is within target at 2.0%.
- CAC payback of 9 months is acceptable, but outbound and events are dragging the average — focus there.
ARR trajectory
Monthly recurring revenue, annualized (€M)
Revenue mix
Share of ARR by stream
- Subscription · 68%
- Usage-based · 19%
- Services · 9%
- Other · 4%
Net burn & runway
Monthly net burn (€K), runway implied from current cash
Implied runway at current burn: ~61 months (assumes €18M cash).
CAC by channel
Cost to acquire a customer and payback in months
Cohort retention
% of customers retained N months after start
| Cohort | M0 | M1 | M2 | M3 | M4 | M5 |
|---|---|---|---|---|---|---|
| 2025-Q1 | 100% | 94% | 90% | 87% | 85% | 84% |
| 2025-Q2 | 100% | 95% | 92% | 90% | 88% | — |
| 2025-Q3 | 100% | 96% | 93% | 91% | — | — |
| 2025-Q4 | 100% | 97% | 95% | — | — | — |
| 2026-Q1 | 100% | 97% | — | — | — | — |
This is what we build, for real
Want one of these reading your own numbers?
In a 20-minute review we'll look at your real KPIs, revenue drivers, churn and bottlenecks — then show the 2–3 reports that would move the needle first.